
South Korea develops world’s 1st recombinant anthrax vaccine
SEOUL — South Korea has developed the world’s first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that could also open export markets for the new vaccine with fewer side effects, the government said. The Korea Disease …